HealthMore in Health→
Drug tariff threats are forcing pharma to rethink trade exposure and pricing strategy
Key Takeaways
- STAT says the Trump administration announced 100% tariffs on imported brand-name drugs.
- The report stresses that the tariffs come with significant caveats.
- The policy could affect pharma pricing, sourcing, and trade strategy even before final implementation details are clear.
DE
DT Editorial Team··via statnews.com